Risk of bias in studies investigating novel diagnostic biomarkers for heart failure with preserved ejection fraction. A systematic review.

MLA

Henkens, Michiel T. H. M., et al. “Risk of Bias in Studies Investigating Novel Diagnostic Biomarkers for Heart Failure with Preserved Ejection Fraction. A Systematic Review.” European Journal of Heart Failure, vol. 22, no. 9, Sept. 2020, pp. 1586–97. EBSCOhost, https://doi.org/10.1002/ejhf.1944.

APA

Henkens, M. T. H. M., Remmelzwaal, S., Robinson, E. L., van Ballegooijen, A. J., Barandiarán Aizpurua, A., Verdonschot, J. A. J., Raafs, A. G., Weerts, J., Hazebroek, M. R., Sanders-van Wijk, S., Handoko, M. L., den Ruijter, H. M., Lam, C. S. P., de Boer, R. A., Paulus, W. J., van Empel, V. P. M., Vos, R., Brunner-La Rocca, H.-P., Beulens, J. W. J., & Heymans, S. R. B. (2020). Risk of bias in studies investigating novel diagnostic biomarkers for heart failure with preserved ejection fraction. A systematic review. European Journal of Heart Failure, 22(9), 1586–1597. https://doi.org/10.1002/ejhf.1944

Chicago

Henkens, Michiel T H M, Sharon Remmelzwaal, Emma L Robinson, Adriana J van Ballegooijen, Arantxa Barandiarán Aizpurua, Job A J Verdonschot, Anne G Raafs, et al. 2020. “Risk of Bias in Studies Investigating Novel Diagnostic Biomarkers for Heart Failure with Preserved Ejection Fraction. A Systematic Review.” European Journal of Heart Failure 22 (9): 1586–97. doi:10.1002/ejhf.1944.